EV/EBITDA
-0.36
0.000.00%
1 min ago
Summary
- As of February 7, 2025, LYRA EV/EBITDA is -0.36, unchanged from the previous trading day.
- Over the past year, LYRA EV/EBITDA has increased by +4.01 (+91.76%).
- LYRA EV/EBITDA is now -162.07% below its all-time high of 0.58.
Performance
LYRA EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
LYRA EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | 0.0% | -1.2% | -2.2% |
| 1 m1 month | +7.7% | -6.8% | -12.2% |
| 3 m3 months | +18.2% | -18.2% | -29.8% |
| 6 m6 months | -5.9% | -3.0% | -37.0% |
| ytdytd | +2.7% | -3.2% | -5.9% |
| 1 y1 year | +91.8% | -91.5% | -96.1% |
| 5 y5 years | - | - | - |
LYRA EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -2.9% | -0.39 | +7.7% | |
| 3 m | 3-month | -0.34 | -5.9% | -0.45 | +20.0% |
| 6 m | 6-month | -0.28 | -28.6% | -0.45 | +20.0% |
| 1 y | 1-year | -0.28 | -28.6% | -5.85 | +93.8% |
| 3 y | 3-year | 0.58 | -162.1% | -5.85 | +93.8% |
| 5 y | 5-year | 0.58 | -162.1% | -11.57 | +96.9% |
| alltime | all time | 0.58 | -162.1% | -11.57 | +96.9% |
Lyra Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.36(-2.7%) |
| 2024 | -0.37(-91.9%) |
| 2023 | -4.58(+249.6%) |
| Date | Value |
|---|---|
| 2022 | -1.31(+351.7%) |
| 2021 | -0.29(-91.5%) |
| 2020 | -3.40 |
FAQ
- What is Lyra Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Lyra Therapeutics?
- What is LYRA EV/EBITDA year-to-date change?
- What is Lyra Therapeutics EV/EBITDA year-on-year change?
What is Lyra Therapeutics EV/EBITDA?
The current EV/EBITDA of LYRA is -0.36
What is the all time high EV/EBITDA for Lyra Therapeutics?
Lyra Therapeutics all-time high EV/EBITDA is 0.58
What is LYRA EV/EBITDA year-to-date change?
Lyra Therapeutics EV/EBITDA has changed by +0.01 (+2.70%) since the beginning of the year
What is Lyra Therapeutics EV/EBITDA year-on-year change?
Over the past year, LYRA EV/EBITDA has changed by +4.01 (+91.76%)